Cargando…

PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer

Gastric cancer (GC) is one of the most prevalent and deadly malignancies worldwide. We aimed to assess the functional role and clinical significance of pyruvate dehydrogenase kinase (PDK) in GC and explored the underlying mechanisms. The bioinformatics method was used to investigate the expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zimu, Han, Shiyuan, Ouyang, Siwen, Zeng, Ziyang, Liu, Zhen, Sun, Juan, Kang, Weiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139696/ https://www.ncbi.nlm.nih.gov/pubmed/35626257 http://dx.doi.org/10.3390/diagnostics12051101

Ejemplares similares

The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
por: Ma, Mingwei, et al.
Publicado: (2022)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

Comparison Among Endoscopic, Laparoscopic, and Open Resection for Relatively Small Gastric Gastrointestinal Stromal Tumors (<5 cm): A Bayesian Network Meta-Analysis
por: Liu, Zhen, et al.
Publicado: (2021)

OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

Correction: OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma
por: Li, Jie, et al.
Publicado: (2022)

The Role and Mechanism of microRNA-1224 in Human Cancer
por: Ma, Mingwei, et al.
Publicado: (2022)

Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study
por: Zeng, Ziyang, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer
por: Li, Jie, et al.
Publicado: (2023)

The Correlation of Prediabetes and Type 2 Diabetes With Adiposity in Adults
por: Sun, Juan, et al.
Publicado: (2022)

Comparisons of nutritional status and complications between patients with and without postoperative feeding jejunostomy tube in gastric cancer: a retrospective study
por: Li, Kang, et al.
Publicado: (2023)

PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)

Rare localization of angiolipoma in the gastrointestinal tract: a case series
por: Sun, Juan, et al.
Publicado: (2020)

Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer
por: Zeng, Ziyang, et al.
Publicado: (2023)

STAT3 enhances the constitutive activity of AGC kinases in melanoma by transactivating PDK1
por: Picco, María Elisa, et al.
Publicado: (2019)

Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis
por: Liu, Zhen, et al.
Publicado: (2022)

Exploration of the role of serum ghrelin in the diagnosis and treatment of digestive tract malignancies
por: Zhu, Changzhen, et al.
Publicado: (2020)

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
por: Ru, Guo-Qing, et al.
Publicado: (2017)

Targeting PDK1 for Chemosensitization of Cancer Cells
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2017)

Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease
por: Yang, Shaobin, et al.
Publicado: (2022)

Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets
por: Ouyang, Jiafeng, et al.
Publicado: (2020)

COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
por: Zeng, Xi, et al.
Publicado: (2020)

PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound
por: Cen, L, et al.
Publicado: (2007)

Tumour‐associated macrophages in gastric cancer: From function and mechanism to application
por: Li, Jie, et al.
Publicado: (2023)

Nucleotide‐Binding Oligomerization Domain (NOD)-Like Receptor Subfamily C (NLRC) as a Prognostic Biomarker for Glioblastoma Multiforme Linked to Tumor Microenvironment: A Bioinformatics, Immunohistochemistry, and Machine Learning-Based Study
por: Han, Shiyuan, et al.
Publicado: (2023)

PKCθ-Mediated PDK1 Phosphorylation Enhances T Cell Activation by Increasing PDK1 Stability
por: Kang, Jung-Ah, et al.
Publicado: (2017)

The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer
por: Yao, Shasha, et al.
Publicado: (2021)

The Landscape of PDK1 in Breast Cancer
por: Wang, Na, et al.
Publicado: (2022)

miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
por: Feng, Lan, et al.
Publicado: (2019)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism
por: Liu, Bin, et al.
Publicado: (2021)

Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
por: Tazawa, Hirofumi, et al.
Publicado: (2021)

AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer
por: Zeng, Yuling, et al.
Publicado: (2022)

MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
por: Li, Zheng, et al.
Publicado: (2016)

CONSTITUTIONAL STUDY OF CANCER PATIENTS – ITS PROGNOSTIC AND THERAPEUTIC SCOPE
por: Venkataraghavan, S., et al.
Publicado: (1987)

The Correlation of Total Percent Fat With Alterations in Cholesterol and Triglycerides in Adults
por: Sun, Juan, et al.
Publicado: (2022)

Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
por: Lucero-Acuña, Armando, et al.
Publicado: (2014)

LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer
por: Xi, Dayong, et al.
Publicado: (2022)

Deficiency of PDK1 in osteoclasts delays fracture healing and repair
por: Xiao, Dongliang, et al.
Publicado: (2020)

Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma
por: Velpula, Kiran K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0cfp89hojgfofh857afoi493rp